MAFEIP
Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing

MD‐Paedigree Clinical Impact Assessment

 

The EU project MD‐Paedigree aims to develop a set of reusable and adaptable multi‐scale models for more predictive, individualised, effective and safer paediatric healthcare, being scientifically and technologically supported by one of the leading industrial actors in medical applications in Europe operating in conjunction with highly qualified SMEs and some of the most experienced research partners in the VPH community.  

The concrete intervention explored in this use case is a model scenario for improved paediatric cardiomyopathy care – a set of chronic and often progressive diseases in which the heart muscle (myocardium) is abnormally enlarged, thickened and/or stiffened. 200 children with cardiovascular disease have been analysed in the project in order to provide clinical and cardiac structural, geometrical and functional data to build the heart model and to validate it afterwards.